(Q41143859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Chin-Hsiao Tseng

series ordinal

1

1 reference

27 September 2017

publication date

13 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

Diabetes - Metabolism: Research and Reviews

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

619-626

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

Ovarian cancer: risk factors, treatment and management

4 March 2020

cites work

1 reference

An international assessment of ovarian cancer incidence and mortality.

21 January 2018

1 reference

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

21 January 2018

1 reference

Use of metformin and the risk of ovarian cancer: a case-control analysis

21 January 2018

1 reference

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

21 January 2018

1 reference

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t

21 January 2018

1 reference

The effects of metformin on ovarian cancer: a systematic review.

21 January 2018

1 reference

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

21 January 2018

1 reference

Bias: considerations for research practice

21 January 2018

1 reference

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

21 January 2018

1 reference

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

21 January 2018

1 reference

Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry.

21 January 2018

1 reference

Human insulin does not increase bladder cancer risk

21 January 2018

1 reference

Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes

21 January 2018

1 reference

Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan

21 January 2018

1 reference

Pioglitazone and bladder cancer: a population-based study of Taiwanese.

21 January 2018

1 reference

Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway

21 January 2018

1 reference

Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study.

21 January 2018

1 reference

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo

21 January 2018

1 reference

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner

21 January 2018

1 reference

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

21 January 2018

1 reference

Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins

21 January 2018

1 reference

Metformin targets ovarian cancer stem cells in vitro and in vivo

21 January 2018

1 reference

Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells.

21 January 2018

1 reference

Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction

21 January 2018

1 reference

Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).

21 January 2018

1 reference

Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort

21 January 2018

1 reference

Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer

21 January 2018

1 reference

Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

The insulin and insulin-like growth factor receptor family in neoplasia: an update

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DMRR.2649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25820555%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference